Insights On Enterprise Solutions
-
Combining Scientific Knowledge And Advanced Technology
2/9/2024
Your partner in contract production and development using the end-to-end business model. We specialize in the production of sterile biotechnological products in a manufacturing plant that meets the requirements of GMP.
-
Adopting Modular, Semi-Automated Approaches To Optimize CGT Development
2/7/2024
There are a number of technology solutions that, when applied to a cell and gene therapy workflow, can streamline development and improve workflow integration.
-
Optimizing Sialic Acid Clone Screening Through A High-Throughput Lectin Assay
2/2/2024
While the traditional high-performance analytical methods used to evaluate glycosylation offer operators high accuracy, their throughput limitations can create time and cost constraints that may hinder development.
-
Inhalable mRNA With Ethris' Carsten Rudolph, Ph.D.
2/1/2024
Without doubt, the grand and collaborative experiment that was the mRNA COVID vaccine contributed mightily to the pandemic response and continues to save lives untold. It also demonstrated the collective power of public/private partnership in biopharma.
-
Closing The Gap Between Theory And Therapy
1/30/2024
A molecule with great therapeutic potential is only as good as its formulation. For patients, a successful formulation closes the gap between theory and therapy.
-
Reducing Risk For Commercial Manufacturing Of Cell And Gene Therapies
1/25/2024
For any biotherapeutic in development today, a critical element in achieving commercialization is reducing manufacturing risk.
-
Guidelines For Choosing The Right mAb Cell Line - Part 1
1/25/2024
mAb success hinges on choosing the right cell line. Learn how making an informed decision helps to lay the foundation for a successful mAb development project, unlocking its full potential.
-
Guidelines For Choosing The Right mAb Cell Line - Part 2
1/25/2024
Learn how a CDMO partner that addresses challenges in CHO cell line development and implements efficient and reliable solutions can enable the efficient production of biopharmaceuticals.
-
The Advantages Of N-1 Process Development For mAb Development
1/25/2024
Explore how N-1 process development can lead to significant improvements in mAb production processes and review considerations for successfully implementing N-1 process development.
-
Uninterrupted Supply To Meet Demand
1/23/2024
Explore a solution for biopharmaceutical companies concerned about the risks an increase in campaign volume can pose to their production timeline.